San Francisco, California-based Hinge Health Inc., a Digital Musculoskeletal (MSK) Clinic™, has named Lex Annison its new Chief Operating Officer.
Lex Annison New COO for Hinge Health
Annison comes to Hinge Health from Google where, as a global director of strategy and operations, he oversaw a team of 3,700 across 18 countries. His focus at Google was scaling and growing Google’s business around the world. Prior to Google, Annison served as head of global operations for Wish and director of worldwide sales and support operations for Facebook. Annison holds a bachelor’s degree in Political Science from BYU and an MBA from Duke University’s Fuqua School of Business.
Annison expressed his excitement about joining the Hinge Health team. He said, “As COO, I’m excited to focus on growing and scaling operations to support Hinge Health’s capabilities so that we can continue advancing our market-leading Digital MSK Clinic.”
He told OTW, “I’m glad to join Hinge Health at a pivotal time for the company as we continue to innovate products to deliver the best care to our participants that translates into a healthy ROI for our customers.”
Hinge Health provides MSK solutions for employers and health plans. Its clinical care model provides members with access to “doctors of physical therapy, physicians, health coaches, and technology such as wearable sensors to guide exercise therapy.”
Hinge Health CEO and Cofounder Dan Perez told OTW, “Lex comes to Hinge Health with a reputation for building and managing large teams. His storied career includes a stint at Cisco after the dot-com bubble, after which he was one of the first few hundred Facebook employees as they grew from a $3B to a $500B company before landing on Google’s Strategy team. He’s a real catch for us and we’re excited for him to lead our operations.”
For OTW’s coverage of Hinge Health’s fundraise, see “Ortho Digital Health Company Raises $300 Million.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.